Clinical Trials Directory

Trials / Sponsors / Hoag Memorial Hospital Presbyterian

Hoag Memorial Hospital Presbyterian

Academic / Other · 31 registered clinical trials4 currently recruiting.

StatusTrialPhaseStarted
Enrolling By InvitationMetastatic Non-Familial Adenocarcinoma Maintenance Therapy With DZ-002: Heptamine Carboxymethine Dye Conjugate
Metastatic Pancreatic Adenocarcinoma, Pancreatic Cancer
Phase 22026-01-01
RecruitingA Phase I Trial of 61Cu-NODAGA-PSMA for Patients with Prostate Cancer
Prostate Adenocarcinoma
Phase 12024-10-14
UnknownStudy of Dotatate Imaging in Breast Cancer
Breast Cancer Stage IV
Phase 22023-01-10
UnknownA Diagnostic Study of CD38-Targeted ImmunoPET of Myeloma
Multiple Myeloma
Phase 22021-03-08
RecruitingPyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer
Prostate Cancer
Phase 22021-02-01
Unknown18F-fluoroestradiol (FES) PET/CT for Breast Cancer
Breast Cancer
Phase 22021-01-15
CompletedPET MRI as a Staging Tool for Head and Neck Cancer
Head Cancer, Neck Cancer
2020-03-03
RecruitingPerioperative Mindfulness Proposal
Breast Cancer, DCIS
N/A2019-07-31
UnknownA Retrospective Trial to Evaluate the Micra Pacemaker
Pacemaker
2019-07-31
UnknownAtrial Fibrillation Ablation Registry
Atrial Fibrillation
2019-05-20
UnknownSTS & ACC Foundation's Transcutaneous Valve Therapy (TVT) Registry Foundation's Transcutaneous Valve Therapy (
Transcutaneous Valve Therapies
2019-05-20
UnknownU01-Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer
Pancreatic Cancer
2018-09-15
CompletedTransition to Adult Care in Type 1 Diabetes
Type1diabetes
2018-09-07
CompletedCoaching for Cognition in Alzheimer's (COCOA)
Alzheimer Disease, Cognitive Impairment
N/A2018-01-10
CompletedEvaluating Outcomes for Ethnically Diverse Patients With Type 2 Diabetes Participating in a Diabetes Education
Type2 Diabetes
N/A2017-08-04
Active Not RecruitingStereotactic Body Radiation Therapy (SBRT) for Prostate Cancer
Prostate Cancer
N/A2016-10-21
CompletedPancreatic Cancer Early Detection Registry
Pancreatic Cancer
2016-10-18
CompletedIntraoperative Radiotherapy for Early Stage Breast Cancer
Breast Cancer
N/A2010-06-01
CompletedVaccine Therapy and GM-CSF in Treating Patients With Recurrent or Metastatic Melanoma
Melanoma (Skin)
Phase 22006-12-01
CompletedCombination Chemotherapy and Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic L
Leukemia, Lymphoma
Phase 22002-06-01
CompletedVaccine Biotherapy of Cancer: Autologous Tumor Cells and Dendritic Cells
Metastatic Melanoma
Phase 22000-10-01
CompletedCellular Adoptive Immunotherapy in Treating Patients With Glioblastoma Multiforme
Brain and Central Nervous System Tumors
Phase 21999-02-01
WithdrawnMonoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Mu
Leukemia, Multiple Myeloma and Plasma Cell Neoplasm
Phase 21998-06-01
WithdrawnCombination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lym
Lymphoma
Phase 21998-06-01
WithdrawnRituximab and Dexamethasone in Treating Patients With Recurrent or Refractory Indolent Non-Hodgkin's Lymphoma
Lymphoma
Phase 21998-06-01
WithdrawnRituximab Plus Cyclophosphamide in Treating Patients With Indolent Stage III or Stage IV Non-Hodgkin's Lymphom
Lymphoma
Phase 21998-05-01
CompletedBiological Therapy in Treating Patients With Metastatic Cancer
Kidney Cancer, Melanoma (Skin), Unspecified Adult Solid Tumor, Protocol Specific
Phase 21996-01-01
CompletedHigh-Dose Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer or Melanoma
Kidney Cancer, Melanoma (Skin)
Phase 21996-01-01
CompletedInterleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
Chronic Myeloproliferative Disorders, Leukemia, Lymphoma
Phase 21992-08-01
CompletedIsotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
Cervical Cancer, Esophageal Cancer, Head and Neck Cancer
Phase 21992-08-01
CompletedTumor Cell Vaccine in Treating Patients With Advanced Cancer
Unspecified Adult Solid Tumor, Protocol Specific
Phase 21992-08-01